News

April 20, 2018April 20, 2018

ATS Foundation/Insmed Announces $50K Research Award in NTM Lung Disease

News

Applications for the new ATS Foundation/Insmed Research Award in Non-Tuberculous Mycobacteria (NTM) Lung Disease will open soon to provide one-year funding of $50,000 to researchers seeking to find better ... Read more

April 17, 2018April 17, 2018

100 Million Chinese Adults Have COPD, but Most Are Unaware of It, Study Reports

News

Nearly 100 million Chinese adults have COPD, but most don’t know they do, a study reported. Heavy air pollution and high smoking rates are two likely reasons for the ... Read more

April 13, 2018April 13, 2018

Tai Chi Improves Respiratory Function in Patients with COPD, Study Shows

News

A group of researchers found that tai chi, an ancient martial art and form of exercise, could offer a low-cost, easily accessible alternative to pulmonary rehabilitation for patients with chronic ... Read more

April 10, 2018April 12, 2018

Treatment with Spiolto Respimat Reduces Rate of COPD Flare-ups Compared to Spiriva Respimat, Study Shows

News

Treatment of chronic obstructive pulmonary disease (COPD) patients with Spiolto Respimat (tiotropium/olodaterol) reduced the rate of moderate-to-severe exacerbations, compared to Spiriva Respimat (tiotropium bromide), in a Phase 3 clinical trial, according to Boehringer ... Read more

April 6, 2018April 6, 2018

Arch Biopartners’ Therapy Candidate AB569 Receives US Patent for Treatment of Chronic Lung Infections

News

AB569, Arch Biopartners’ lead therapy candidate, has received a U.S. patent for the treatment of chronic lung infections in patients with chronic obstructive pulmonary disease (COPD) or cystic fibrosis. Patent ... Read more

April 3, 2018April 3, 2018

Verona’s RPL554 Seems to Improve COPD Lung Function, Trial Results Show

News

Treatment with Verona Pharma’s investigative drug RPL554 can effectively improve lung function in patients with chronic obstructive pulmonary disease (COPD), results from a Phase 2b trial showed. The trial ... Read more

March 27, 2018March 27, 2018

Genome of Dangerous Pathogen Deciphered in 15-year Study of COPD Patients

News

A 15-year study demonstrated how nontypeable Haemophilus influenzae (NTHi), one of the most important pathogens in chronic obstructive pulmonary disease (COPD), adapts and survives in patients’ airways over time. The ... Read more

March 23, 2018March 23, 2018

PDGFD Gene Mutation Linked to Increased Risk of Corticosteroid-Induced Adrenal Suppression

News

A mutation of the PDGFD gene is linked to an increased risk of adrenal gland suppression, a serious side effect of inhaled corticosteroids used to treat asthma and chronic obstructive ... Read more

March 20, 2018March 20, 2018

Long-term Aspirin Use Reduces Severity of Acute COPD Exacerbations, Study Reports

News

The long-term use of aspirin was found to reduce the severity of acute exacerbations in chronic obstructive pulmonary disease (AECOPD), including in-hospital mortality, invasive ventilation use, and hospital length-of-stay (LOS), ... Read more

March 16, 2018March 16, 2018

BODE Score May Need Reevaluation for Lung Transplant Screening, Study Suggests

News

Survival in patients with chronic obstructive pulmonary disease (COPD) in need of lung transplantation might be considerably better than previously predicted, a new study recently published in the journal CHEST suggested. ... Read more

Pin It on Pinterest